Literature DB >> 12667822

Investigations into the amino-terminal domain of the respiratory syncytial virus nucleocapsid protein reveal elements important for nucleocapsid formation and interaction with the phosphoprotein.

Lindsay B Murphy1, Colin Loney, Jillian Murray, David Bhella, Peter Ashton, Robert P Yeo.   

Abstract

Bacterially expressed nucleocapsid (N) protein, from respiratory syncytial virus (RSV), was used to investigate RNA binding in a modified North-Western blotting protocol. The recombinant protein demonstrated no sequence specificity in binding RNA representing either the antigenomic leader sequence or the nonspecific sequence derived from a plasmid vector. When recombinant N was purified on CsCl gradients, two types of structure, both with densities indicating that they contained RNA, could be visualised by negative-stain electron microscopy. Structures similar to nucleocapsids (NC) from RSV-infected cells were observed, as were ring structures. A small fragment of the N (amino acids 1-92) was all that was required for the production of NC-like structures. Another mutant with an internal deletion could form rings but not NC-like structures. This suggests that this domain (amino acids 121-160) may be important for maintaining helical stability. Further analysis has also identified a potential site in the amino-terminus that may be involved in an interaction with the phosphoprotein. A domain model of the RSV N protein is presented which, similar to that of other paramyxoviruses, supports the idea that the amino-terminus is important for NC assembly.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12667822     DOI: 10.1016/s0042-6822(02)00063-6

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  17 in total

1.  Characterization of a viral phosphoprotein binding site on the surface of the respiratory syncytial nucleoprotein.

Authors:  Marie Galloux; Bogdan Tarus; Ilfad Blazevic; Jenna Fix; Stéphane Duquerroy; Jean-François Eléouët
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

2.  Identification of internal sequences in the 3' leader region of human respiratory syncytial virus that enhance transcription and confer replication processivity.

Authors:  David R McGivern; Peter L Collins; Rachel Fearns
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

3.  Functional mapping of the nucleoprotein of Ebola virus.

Authors:  Shinji Watanabe; Takeshi Noda; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

4.  Mapping of the VP40-binding regions of the nucleoprotein of Ebola virus.

Authors:  Takeshi Noda; Shinji Watanabe; Hiroshi Sagara; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

5.  Surface features of a Mononegavirales matrix protein indicate sites of membrane interaction.

Authors:  Victoria A Money; Helen K McPhee; Jackie A Mosely; John M Sanderson; Robert P Yeo
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-26       Impact factor: 11.205

6.  Association of respiratory syncytial virus M protein with viral nucleocapsids is mediated by the M2-1 protein.

Authors:  Dongsheng Li; David A Jans; Phillip G Bardin; Jayesh Meanger; John Mills; Reena Ghildyal
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

7.  Mutational analysis reveals a noncontractile but interactive role of actin and profilin in viral RNA-dependent RNA synthesis.

Authors:  Mary Harpen; Tiasha Barik; Alla Musiyenko; Sailen Barik
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

8.  Purification and characterization of Nipah virus nucleocapsid protein produced in insect cells.

Authors:  Majid Eshaghi; Wen Siang Tan; Swee Tin Ong; Khatijah Yusoff
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

9.  RSV604, a novel inhibitor of respiratory syncytial virus replication.

Authors:  Joanna Chapman; Elizabeth Abbott; Dagmar G Alber; Robert C Baxter; Sian K Bithell; Elisa A Henderson; Malcolm C Carter; Phil Chambers; Ann Chubb; G Stuart Cockerill; Peter L Collins; Verity C L Dowdell; Sally J Keegan; Richard D Kelsey; Michael J Lockyer; Cindy Luongo; Pilar Najarro; Raymond J Pickles; Mark Simmonds; Debbie Taylor; Stan Tyms; Lara J Wilson; Kenneth L Powell
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

10.  Human metapneumovirus nucleoprotein and phosphoprotein interact and provide the minimal requirements for inclusion body formation.

Authors:  Aaron Derdowski; Timothy R Peters; Nancy Glover; Ray Qian; Thomas J Utley; Atuhani Burnett; John V Williams; Paul Spearman; James E Crowe
Journal:  J Gen Virol       Date:  2008-11       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.